Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Corcel planning next drawdown from convertible loan facility

(Sharecast News) - Corcel updated the market on its unsecured convertible loan note facility on Friday. The AIM-traded firm said the facility, with a potential extension of £10m in funding, carried a 12% interest rate per annum and offered conversion into new ordinary shares over the three-year lifespan of the notes, at a fixed price of £0.008.

To date, £1m had been drawn down from the facility, with £0.25m of that amount subsequently converted into equity, as confirmed in an announcement on 2 January.

Corcel said it was currently in discussions with the lender, Extraction, regarding the quantum and timing of the next drawdown against the facility.

The company said it would provide updates regarding the discussions in due course, adding that it expected the proceeds from the drawdown to be used to support its ongoing activities in the Kwanza Basin, Angola.

Corcel noted that Extraction is 45% owned by Antoine Karam, the company's executive chairman.

At 1143 GMT, shares in Corcel were down 5.88% at 0.8p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Sirius Real Estate ups dividend as profits jump 32%
(Sharecast News) - Profits at business and industrial parks developer Sirius Real Estate surged by nearly a third in the year ended 31 March, helping the company to increase dividends for the tenth straight year.
GSK to appeal Delaware ruling on jury trials in Zantac cancer cases
(Sharecast News) - Pharma giant GSK said it would be appealing against a US court decision allowing jury trials in cases brought by cancer sufferers claiming its heartburn drug caused their condition.
AstraZeneca's lung cancer treatment recommended for approval in EU
(Sharecast News) - AstraZeneca has announced that its Tagrisso treatment for advanced lung cancer, when combined with chemotherapy, has been recommended for approval by European regulators.
China manufacturing PMI ticks up more than expected - Caixin
(Sharecast News) - Activity in China's manufacturing sector grew in May at the fastest rate in two years, according to data released on Monday.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.